August 20, 2015
Natcher Conference Center (NIH Campus) 45 Center Drive Bethesda, MD 20892
The NHLBI Annual Sickle Cell Disease Clinical Trials Meetings provide a yearly forum for investigators, practitioners, and interested health care providers to discuss the progress of ongoing clinical trials, hear presentations about new developments in scientific and clinical aspects of SCD, and interact with other investigators and NHLBI Program Staff. This year, the meeting will begin on August 18, 2015 and end on August 20, 2015. Scheduled presentations include a two-part symposium on basic and clinical aspects of sickle cell pain, a symposium on the current status of hematopoietic stem cell transplantation in SCD, and a session focusing on using Patient Reported Outcomes in clinical SCD research. This meeting is an opportunity to meet and exchange ideas with diverse group of SCD investigators and providers, as well as NIH Program Officers in an informal setting.
September 29, 2015 to September 30, 2015
Natcher Conference Center (Building 45), National Institutes of Health, Bethesda, Maryland
The event will bring together experts in stem cell biology, cardiovascular development, translating stem cell biology, cardiac remodelling and inflammation, vascular remodelling and inflammation, and tissue engineering/genome editing/new technologies. The emphasis will be on recent discoveries and trends. We will examine the challenges and critical questions that require answers as the field moves forward to clinical applications. The Symposium’s goals are to help the science and field move forward, to find consensus regarding the translation of stem cell biology and research into a clinical setting, and to inspire participants in their own work.